Skip to main content
Top
Published in: Calcified Tissue International 6/2015

01-12-2015 | Original Research

Age-Related Effects of Advanced Glycation End Products (Ages) in Bone Matrix on Osteoclastic Resorption

Authors: Xiao Yang, Chintan Gandhi, MD. Mizanur Rahman, Mark Appleford, Lian-Wen Sun, Xiaodu Wang

Published in: Calcified Tissue International | Issue 6/2015

Login to get access

Abstract

Advanced glycation end products (AGEs) accumulate in bone extracellular matrix as people age. Previous studies have shown controversial results regarding the role of in situ AGEs accumulation in osteoclastic resorption. To address this issue, this study cultured human osteoclast cells directly on human cadaveric bone slices from different age groups (young and elderly) to warrant its relevance to in vivo conditions. The cell culture was terminated on the 3rd, 7th, and 10th day, respectively, to assess temporal changes in the number of differentiated osteoclasts, the number and size of osteoclastic resorption pits, the amount of bone resorbed, as well as the amount of matrix AGEs released in the medium by resorption. In addition, the in situ concentration of matrix AGEs at each resorption pit was also estimated based on its AGEs autofluorescent intensity. The results indicated that (1) osteoclastic resorption activities were significantly correlated with the donor age, showing larger but shallower resorption pits on the elderly bone substrates than on the younger ones; (2) osteoclast resorption activities were not significantly dependent on the in situ AGEs concentration in bone matrix, and (3) a correlation was observed between osteoclast activities and the concentration of AGEs released by the resorption. These results suggest that osteoclasts tend to migrate away from initial anchoring sites on elderly bone substrate during resorption compared to younger bone substrates. However, such behavior is not directly related to the in situ concentration of AGEs in bone matrix at the resorption sites.
Literature
1.
go back to reference Ji JD, Woo JH, Choi SJ et al (2009) Advanced glycation end-products (ages): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis. Med Hypotheses 2:201–202CrossRef Ji JD, Woo JH, Choi SJ et al (2009) Advanced glycation end-products (ages): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis. Med Hypotheses 2:201–202CrossRef
2.
go back to reference Valcourt U, Merle B, Gineyts E et al (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 8:5691–5703CrossRef Valcourt U, Merle B, Gineyts E et al (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 8:5691–5703CrossRef
3.
go back to reference Wautier JL, Paton RC, Wautier MP et al (1981) Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 5:237CrossRef Wautier JL, Paton RC, Wautier MP et al (1981) Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 5:237CrossRef
4.
go back to reference Stevens VJ, Rouzer CA, Monnier VM et al (1978) Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA 6:2918–2922CrossRef Stevens VJ, Rouzer CA, Monnier VM et al (1978) Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA 6:2918–2922CrossRef
5.
go back to reference McCann VJ, Davis RE (1979) Glycosylated hemoglobin concentrations in patients with diabetic neuropathy. Acta Diabetol Lat 3:205–209CrossRef McCann VJ, Davis RE (1979) Glycosylated hemoglobin concentrations in patients with diabetic neuropathy. Acta Diabetol Lat 3:205–209CrossRef
6.
go back to reference Viberti GC, Pickup JC, Jarrett RJ et al (1979) Effect of control of blood glucose on urinary excretion of albumin and β2 microglobulin in insulin-dependent diabetes. N Engl J Med 12:638–641CrossRef Viberti GC, Pickup JC, Jarrett RJ et al (1979) Effect of control of blood glucose on urinary excretion of albumin and β2 microglobulin in insulin-dependent diabetes. N Engl J Med 12:638–641CrossRef
7.
go back to reference Takagi M, Kasayama S, Yamamoto T et al (1997) Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. J Bone Miner Res 3:439–446CrossRef Takagi M, Kasayama S, Yamamoto T et al (1997) Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. J Bone Miner Res 3:439–446CrossRef
8.
go back to reference Dyer DG, Blackledge JA, Thorpe SR et al (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 18:11654–11660 Dyer DG, Blackledge JA, Thorpe SR et al (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 18:11654–11660
9.
go back to reference Tang SY, Vashishth D (2010) Non-enzymatic glycation alters microdamage formation in human cancellous bone. Bone 1:148–154CrossRef Tang SY, Vashishth D (2010) Non-enzymatic glycation alters microdamage formation in human cancellous bone. Bone 1:148–154CrossRef
10.
go back to reference Karim L, Tang SY, Sroga GE et al (2013) Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone. Osteoporos Int 9:2441–2447CrossRef Karim L, Tang SY, Sroga GE et al (2013) Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone. Osteoporos Int 9:2441–2447CrossRef
11.
go back to reference McCarthy AD, Etcheverry SB, Bruzzone L et al (1997) Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells. Mol Cell Biochem 1–2:43–51CrossRef McCarthy AD, Etcheverry SB, Bruzzone L et al (1997) Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells. Mol Cell Biochem 1–2:43–51CrossRef
12.
go back to reference McCarthy AD, Etcheverry SB, Bruzzone L et al (2001) Non-enzymatic glycosylation of a type i collagen matrix: Effects on osteoblastic development and oxidative stress. BMC cell biology 2:16PubMedCentralCrossRefPubMed McCarthy AD, Etcheverry SB, Bruzzone L et al (2001) Non-enzymatic glycosylation of a type i collagen matrix: Effects on osteoblastic development and oxidative stress. BMC cell biology 2:16PubMedCentralCrossRefPubMed
13.
go back to reference Mercer N, Ahmed H, Etcheverry SB et al (2007) Regulation of advanced glycation end product (age) receptors and apoptosis by ages in osteoblast-like cells. Mol Cell Biochem 1–2:87–94CrossRef Mercer N, Ahmed H, Etcheverry SB et al (2007) Regulation of advanced glycation end product (age) receptors and apoptosis by ages in osteoblast-like cells. Mol Cell Biochem 1–2:87–94CrossRef
14.
go back to reference Alikhani Z, Alikhani M, Boyd C et al (2007) Advanced glycation end products stimulate osteoblast apoptosis via the map kinase and cytosolic apoptotic pathways. Bone 2:345–353CrossRef Alikhani Z, Alikhani M, Boyd C et al (2007) Advanced glycation end products stimulate osteoblast apoptosis via the map kinase and cytosolic apoptotic pathways. Bone 2:345–353CrossRef
15.
go back to reference Zhu XF, Wang TC, Zhang RH (2012) Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro. Zhongguo Zhong Xi Yi Jie He Za Zhi 4:525–529 Zhu XF, Wang TC, Zhang RH (2012) Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro. Zhongguo Zhong Xi Yi Jie He Za Zhi 4:525–529
16.
go back to reference Franke S, Ruster C, Pester J et al (2011) Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol 4:650–660 Franke S, Ruster C, Pester J et al (2011) Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol 4:650–660
17.
go back to reference Hein G, Weiss C, Lehmann G et al (2006) Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 1:101–104CrossRef Hein G, Weiss C, Lehmann G et al (2006) Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 1:101–104CrossRef
18.
go back to reference Miyata T, Notoya K, Yoshida K et al (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 2:260–270 Miyata T, Notoya K, Yoshida K et al (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 2:260–270
19.
go back to reference Yamagishi S, Nakamura K, Inoue H (2005) Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses 6:1013–1015CrossRef Yamagishi S, Nakamura K, Inoue H (2005) Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses 6:1013–1015CrossRef
20.
go back to reference Dong XN, Qin A, Xu J et al (2011) In situ accumulation of advanced glycation end products (ages) in bone matrix and its correlation with osteoclastic bone resorption. Bone 2:174–183CrossRef Dong XN, Qin A, Xu J et al (2011) In situ accumulation of advanced glycation end products (ages) in bone matrix and its correlation with osteoclastic bone resorption. Bone 2:174–183CrossRef
21.
go back to reference Luevano-Contreras C, Chapman-Novakofski K (2010) Dietary advanced glycation end products and aging. Nutrients 12:1247–1265CrossRef Luevano-Contreras C, Chapman-Novakofski K (2010) Dietary advanced glycation end products and aging. Nutrients 12:1247–1265CrossRef
22.
go back to reference Hein G, Wiegand R, Lehmann G et al (2003) Advanced glycation end-products pentosidine and n epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 10:1242–1246CrossRef Hein G, Wiegand R, Lehmann G et al (2003) Advanced glycation end-products pentosidine and n epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 10:1242–1246CrossRef
23.
go back to reference Rumpler M, Würger T, Roschger P et al (2012) Microcracks and osteoclast resorption activity in vitro. Calcif Tissue Int 3:230–238CrossRef Rumpler M, Würger T, Roschger P et al (2012) Microcracks and osteoclast resorption activity in vitro. Calcif Tissue Int 3:230–238CrossRef
24.
go back to reference Chang P-C, Chung M-C, Wang Y-P et al (2012) Patterns of diabetic periodontal wound repair: a study using micro-computed tomography and immunohistochemistry. J Periodontol 5:644–652CrossRef Chang P-C, Chung M-C, Wang Y-P et al (2012) Patterns of diabetic periodontal wound repair: a study using micro-computed tomography and immunohistochemistry. J Periodontol 5:644–652CrossRef
25.
go back to reference Hein GE (2006) Glycation endproducts in osteoporosis—is there a pathophysiologic importance? Clin Chim Acta 1–2:32–36CrossRef Hein GE (2006) Glycation endproducts in osteoporosis—is there a pathophysiologic importance? Clin Chim Acta 1–2:32–36CrossRef
26.
go back to reference Schwartz AV, Garnero P, Hillier TA et al (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 7:2380–2386CrossRef Schwartz AV, Garnero P, Hillier TA et al (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 7:2380–2386CrossRef
27.
go back to reference Zhou Z, Immel D, Xi CX et al (2006) Regulation of osteoclast function and bone mass by rage. J Exp Med 4:1067–1080CrossRef Zhou Z, Immel D, Xi CX et al (2006) Regulation of osteoclast function and bone mass by rage. J Exp Med 4:1067–1080CrossRef
28.
go back to reference Charoonpatrapong K, Shah R, Robling AG et al (2006) Hmgb1 expression and release by bone cells. J Cell Physiol 2:480–490CrossRef Charoonpatrapong K, Shah R, Robling AG et al (2006) Hmgb1 expression and release by bone cells. J Cell Physiol 2:480–490CrossRef
29.
go back to reference Zhou Z, Han JY, Xi CX et al (2008) Hmgb1 regulates rankl-induced osteoclastogenesis in a manner dependent on rage. J Bone Miner Res 7:1084–1096CrossRef Zhou Z, Han JY, Xi CX et al (2008) Hmgb1 regulates rankl-induced osteoclastogenesis in a manner dependent on rage. J Bone Miner Res 7:1084–1096CrossRef
30.
go back to reference Burr DB (1993) Remodeling and the repair of fatigue damage. Calcif Tissue Int 53:S75–S80 discussion S80-1 CrossRefPubMed Burr DB (1993) Remodeling and the repair of fatigue damage. Calcif Tissue Int 53:S75–S80 discussion S80-1 CrossRefPubMed
31.
go back to reference Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 6:521–525CrossRef Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 6:521–525CrossRef
32.
go back to reference Barrere F, van Blitterswijk CA, de Groot K (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomed 3:317–332 Barrere F, van Blitterswijk CA, de Groot K (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomed 3:317–332
33.
go back to reference Hofmann B, Adam A-C, Jacobs K et al (2013) Advanced glycation end product associated skin autofluorescence: a mirror of vascular function? Exp Gerontol 1:38CrossRef Hofmann B, Adam A-C, Jacobs K et al (2013) Advanced glycation end product associated skin autofluorescence: a mirror of vascular function? Exp Gerontol 1:38CrossRef
34.
go back to reference Vashishth D, Gibson GJ, Khoury JI et al (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 2:195–201CrossRef Vashishth D, Gibson GJ, Khoury JI et al (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 2:195–201CrossRef
Metadata
Title
Age-Related Effects of Advanced Glycation End Products (Ages) in Bone Matrix on Osteoclastic Resorption
Authors
Xiao Yang
Chintan Gandhi
MD. Mizanur Rahman
Mark Appleford
Lian-Wen Sun
Xiaodu Wang
Publication date
01-12-2015
Publisher
Springer US
Published in
Calcified Tissue International / Issue 6/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0042-1

Other articles of this Issue 6/2015

Calcified Tissue International 6/2015 Go to the issue